Tarsus Pharmaceuticals, Inc. TARS Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s invested capital?
- Tarsus Pharmaceuticals, Inc. (TARS) reported invested capital of $333.43M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s invested capital changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s invested capital increased by 41.0% year-over-year, from $236.48M to $333.43M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s invested capital has grown at a 182.4% compound annual growth rate (CAGR), from -$1.34M to $240.26M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).